MD
Malcom Deane
ALS Limited | Chief Strategy Officer, General Manager, Life Sciences - Food & Pharma Americas, General, Chief Executive Officer, Managing Director
Company and Roles
Company | Title | Tenure | Since |
---|---|---|---|
ALS Limited |
| 1yrs, 9mth | Mar 2023 |
Holding
Company | Last Notice | Direct Shares | Indirect Shares | Options | Convertibles |
---|---|---|---|---|---|
ALS Limited | 01/07/24 | 37,032 | N/A | N/A | N/A |
Transactions
Company | Date | Type | Amount | Price | Value | Notes |
---|---|---|---|---|---|---|
ALS Limited | 31/07/24 | Issued | 163,082 | $14.130 | $2,304,360 | Issue of securities |
ALS Limited | 01/07/24 | Expiry | 424 | $14.038 | $5,952 | As advised by the company |
ALS Limited | 01/07/24 | Exercise | 21,486 | $14.040 | $301,663 | Conversion of securities |
ALS Limited | 01/07/24 | Issued | 18,088 | $14.040 | $253,955 | Issue of securities |
ALS Limited | 01/07/24 | Buy | 21,486 | $14.040 | $301,663 | Conversion of securities |
Any feedback about this profile? Contact Us